Results 71 to 80 of about 4,484 (145)

Multi-Target Inhibition of F10/F2/PAR1 Through In Silico Drug Repurposing of Avodart and Naldemedine to Prevent Thrombotic-Induced Sudden Cardiac Arrest. [PDF]

Biomedicines
Al-Subaie AM, AbdulAzeez S.
europepmc   +1 more source

Repurposing antiviral drugs targeting RNA viruses: A focus on the fusion protein of human metapneumovirus. [PDF]

North Clin Istanb
Aras M, Yayintas OT.
europepmc   +1 more source

Anti-HCV NS2-3 potential of selected plant bioactive compounds revealed by docking, simulation and DFT. [PDF]

Sci Rep
Mboto CI, Mbim EN, Edet UO, Lugos M, Abdalla M, Ndifon WO, Ebenso EE, Udo SI, Egharevba HO, George UE, El-Sayed MH, Abdalla SF.   +11 more
europepmc   +1 more source

Identification of Candidate Inhibitors to SARS-CoV-2's Enzymes and Potential Disruptors of Its Structural Proteins' Interactions. [PDF]

Adv Biomed Res
Mohammadian A, Jadaliha M, Imanpour A, Pourvali Moghadam H, Jahangir A.   +4 more
europepmc   +1 more source

Efficacy and Safety of Direct-Acting Antivirals in Patients with Hepatitis C Infection: Nationwide Real-life Data from Türkiye. [PDF]

Turk J Gastroenterol
Gunduz A, Öztoprak NÇ, Sarı ND, Kurtaran B, Önlen Y, Senates E, Zerdali E, Karsen H, Batırel A, Ali RK, Güner R, Yamazhan T, Kose S, Erben N, Ince N, Köksal İ, Sarıgül Yıldırım F, Yoruk G, Komur S, Bal T, Kaya S, Esen Ş, Günal Ö, Yıldız IE, Inan D, Barut Ş, Namıduru M, Tosun S, Türker K, Sener A, Hızel K, Baykam N, Duygu F, Akıncı E, Can G, User U, Gül HC, Akbulut A, Çelebi G, Sünnetçioğlu M, Karabay O, Kumbasar Karaosmanoğlu H, Sırmatel F, Tabak F, Hep-C Turkey Study Group.   +44 more
europepmc   +1 more source

A Box-Behnken design-assisted RP-HPLC method development and optimization for simultaneous determination of four antiviral drugs in pharmaceutical dosage forms. [PDF]

Sci Rep
Ghazy FH, El-Bagary RI, Fahim SH, Mahmoud ST.   +3 more
europepmc   +1 more source

Plasma proteome-wide Mendelian randomization reveals multi-ancestry drug targets for gastric cancer. [PDF]

Front Oncol
Zhi P, Cui Y, Xue G, Qiao L, Geng J, Chang Z, Xu Y, Yan J, Wang Y, Zhao C.   +9 more
europepmc   +1 more source

Short-Term Clinical and Immunologic Outcomes Conditional on SVR12 in Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Treated With Direct-Acting Antivirals: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Boonpheng B, Ungprasert P.
europepmc   +1 more source

Consideration of ledipasvir/sofosbuvir as an alternative to glecaprevir/pibrentasvir based upon on-treatment FIB-4 changes and sustained virologic response at 12 weeks in hepatitis C genotype 1 and 2 infections: A propensity score-matched study. [PDF]

Medicine (Baltimore)
Park HJ, Wang H, Jeong J, Seo KI, Shin JW, Park NH.   +5 more
europepmc   +1 more source

Sensitive RP-HPLC method with fluorimetric detection for concurrent quantification of emtricitabine, Daclatasvir and Ledipasvir in human urine. [PDF]

Sci Rep
Youssef AA, Magdy N, Hussein LA, El-Kosasy AM.   +3 more
europepmc   +1 more source